Tamara van Donge

Chapter 10 214 Supporting information Table S1: Total samples per kidney biomarker. LLOQ; lower limit of quantification, ULOQ; upper limit of quantification; outliers were removed from statistical analysis based on Tukey et al. 27 Biomarker Excluded Low volume LLOQ Albumin, g/L 15 1 / Creatinine (Enzymatic), µmol/L 15 1 / Uromodulin, µg/L 15 2 / Cystatin C, mg/L 15 9 / Beta-trace protein, mg/L 15 7 / Beta 2-microglobulin, mg/L 15 9 / Neutrophil gelatinase associated lipocalin, µg/L 15 1 / Kidney injury molecule 1, ng/L 15 4 16 (<150 pg/mL) Table S2: Additional information on demographic characteristics of included patients. 0-2 years (N=20) 2-5 years (N=22) Type of surgery Diagnostic procedure 0 (0%) 0 (0%) ENT surgery 1 (5%) 12 (54.5%) Visceral surgery 17 (85%) 9 (40.9%) Neurosurgery 2 (10%) 0 (0%) Orthopedic surgery 0 (0%) 1 (4.5%) Systolic blood pressure, mm/Hg Mean (SD) 92 (14.81) 97.32 (14.78) Median (Q1, Q3) 87.5 (83.7, 96.3) 90 (85, 108.75) Diastolic blood pressure, mm/Hg Mean (SD) 52.15 (14.65) 52.55 (15.05) Median (Q1, Q3) 45 (40, 66.3) 50 (40, 57.25)